Literature DB >> 27484500

Biological study of the effect of water soluble [N-(2-hydroxybenzyl)-L-aspartato] gallium complexes on breast carcinoma and fibrosarcoma cells.

Ahmed Mohsen1,2,3, Charles Saby3, Philippe Collery4, Gilane Mohamed Sabry2, Rasha Elsherif Hassan2, Abdelfattah Badawi5, Pierre Jeannesson3, Didier Desmaële6, Hamid Morjani7.   

Abstract

Two water soluble gallium complexes described as [Ga(III)LCl], where L is the deprotonated form of N-2-hydroxybenzyl aspartic acid derivatives, were synthesized and characterized by (1)H NMR, (13)C NMR, FT-IR, mass spectrometry, and elemental analysis. The 2-(5-chloro-2-hydroxybenzylamino)succinic acid derivative (GS2) has been found to be a promising anticancer drug candidate. This compound was found to be more cytotoxic against human breast carcinoma MDA-MB231 and fibrosarcoma HT-1080 cell lines than the unsubstituted derivative and GaCl3. GS2 was able to induce apoptosis through downregulation of AKT phosphorylation, G2M arrest in cell cycle, and caspase 3/7 pathway. This gallium complex was found to induce an increase in mitochondrial ROS level in HT-1080 cells but not in MDA-MB231 cells. This suggests that the mechanism of action of GS2 would not be mediated by the drug-induced oxidative stress but probably by directly and indirectly inhibiting the AKT cell-signaling pathway.

Entities:  

Keywords:  Antitumor activity; Apoptosis; Gallium complex; Reactive oxygen species; Tridendate ligand

Mesh:

Substances:

Year:  2016        PMID: 27484500     DOI: 10.1007/s00775-016-1382-7

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  33 in total

1.  Toxicity and antitumor activity of gallium nitrate and periodically related metal salts.

Authors:  M M Hart; C F Smith; S T Yancey; R H Adamson
Journal:  J Natl Cancer Inst       Date:  1971-11       Impact factor: 13.506

2.  Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma.

Authors:  Mei-Sze Chua; Lawrence R Bernstein; Rui Li; Samuel K S So
Journal:  Anticancer Res       Date:  2006 May-Jun       Impact factor: 2.480

3.  Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588).

Authors:  A Y Chang; Z N Tu; J L Smith; P Bonomi; T J Smith; P H Wiernik; R Blum
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

Review 4.  Gallium and its competing roles with iron in biological systems.

Authors:  Christopher R Chitambar
Journal:  Biochim Biophys Acta       Date:  2016-05-03

5.  Vinblastine, ifosfamide, and gallium nitrate--an active new regimen in patients with advanced carcinoma of the urothelium. A phase II trial of the Eastern Cooperative Oncology Group (E5892).

Authors:  R Dreicer; K J Propert; B J Roth; L H Einhorn; P J Loehrer
Journal:  Cancer       Date:  1997-01-01       Impact factor: 6.860

6.  Clinical pharmacology of gallium chloride after oral administration in lung cancer patients.

Authors:  P Collery; H Millart; D Lamiable; R Vistelle; P Rinjard; G Tran; B Gourdier; C Cossart; J C Bouana; C Pechery
Journal:  Anticancer Res       Date:  1989 Mar-Apr       Impact factor: 2.480

7.  Synthesis, Structure, and Antiproliferative Activity of Three Gallium(III) Azole Complexes.

Authors:  Stergios Zanias; Giannis S Papaefstathiou; Catherine P Raptopoulou; Konstantinos T Papazisis; Vasiliki Vala; Dimitra Zambouli; Alexandros H Kortsaris; Dimitrios A Kyriakidis; Theodoros F Zafiropoulos
Journal:  Bioinorg Chem Appl       Date:  2010-07-18       Impact factor: 7.778

Review 8.  Gallium in cancer treatment.

Authors:  Philippe Collery; Bernhard Keppler; Claudie Madoulet; Bernard Desoize
Journal:  Crit Rev Oncol Hematol       Date:  2002-06       Impact factor: 6.312

9.  Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells.

Authors:  Milena R Kaluđerović; Marija Mojić; Santiago Gómez-Ruiz; Sanja Mijatović; Danijela Maksimović-Ivanić
Journal:  Anticancer Agents Med Chem       Date:  2016       Impact factor: 2.505

10.  Development of gallium compounds for treatment of lymphoma: gallium maltolate, a novel hydroxypyrone gallium compound, induces apoptosis and circumvents lymphoma cell resistance to gallium nitrate.

Authors:  Christopher R Chitambar; David P Purpi; Jeffrey Woodliff; Meiying Yang; Janine P Wereley
Journal:  J Pharmacol Exp Ther       Date:  2007-06-28       Impact factor: 4.030

View more
  2 in total

1.  Synthesis, crystal structure and antiproliferative mechanisms of gallium(iii) complexes with benzoylpyridine thiosemicarbazones.

Authors:  Jinxu Qi; Taichen Liu; Wei Zhao; Xinhua Zheng; Yihong Wang
Journal:  RSC Adv       Date:  2020-05-18       Impact factor: 4.036

2.  Equilibria in Aqueous Cobalt(II)-Reduced Schiff Base N-(2-hydroxybenzyl)alanine System: Chemical Characterization, Kinetic Analysis, Antimicrobial and Cytotoxic Properties.

Authors:  Magdalena Woźniczka; Manas Sutradhar; Armando J L Pombeiro; Mirosława Świątek; Marek Pająk; Joanna Gądek-Sobczyńska; Magdalena Chmiela; Weronika Gonciarz; Beata Pasternak; Aleksander Kufelnicki
Journal:  Molecules       Date:  2020-07-30       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.